PROHANCE

This brand name is authorized in Austria, Brazil, Canada, Croatia, Estonia, Finland, France, Ireland, Japan, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug PROHANCE contains one active pharmaceutical ingredient (API):

1	Gadoteridol UNII 0199MV609F - GADOTERIDOL
	Gadoteridol is a non-ionic paramagnetic contrast medium for Magnetic Resonance Imaging. Gadoteridol is for diagnostic use only.
	Read more about Gadoteridol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PROHANCE Solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V08CA04	Gadoteridol	V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media
Discover more medicines within V08CA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	540700201158419, 540700202154417, 540700203150415
CA	Health Products and Food Branch	02229056
EE	Ravimiamet	1778632, 1778643, 1778654, 1778665, 1778687, 1778698, 1778700
ES	Centro de información online de medicamentos de la AEMPS	60377, 64474
FI	Lääkealan turvallisuus- ja kehittämiskeskus	539411, 539429, 539437, 539445
FR	Base de données publique des médicaments	61258225, 69155907
GB	Medicines & Healthcare Products Regulatory Agency	399427, 399429, 399431, 399433, 399435
HR	Agencija za lijekove i medicinske proizvode	HR-H-668102412
JP	医薬品医療機器総合機構	7290407A1031, 7290407A2038, 7290407A3034, 7290407A4030, 7290407G1034, 7290407G2030
LT	Valstybinė vaistų kontrolės tarnyba	1087973, 1087974, 1087975, 1087976, 1087977, 1087978, 1087979, 1087980, 1087981, 1087982, 1087983, 1087984, 1087985, 1091482, 1091483
PL	Rejestru Produktów Leczniczych	100097278
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W66183001, W66183002, W66183003, W66183004, W66183005, W66183006, W66183007, W66183008, W66184001, W66184002, W66184003, W66184004, W66184005, W66184006, W66184007, W66184008, W66184009
US	FDA, National Drug Code	0270-1111